Aurobindo Pharma Limited (AUROPHARMA.NS)
INR 1257.8
(0.88%)
INR 1257.8
(0.88%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 290.01 Billion INR | 17.81% |
| 2022 | 246.17 Billion INR | 5.35% |
| 2021 | 233.66 Billion INR | -4.85% |
| 2020 | 245.57 Billion INR | 8.0% |
| 2019 | 227.37 Billion INR | 18.27% |
| 2018 | 192.25 Billion INR | 18.68% |
| 2017 | 161.99 Billion INR | 10.47% |
| 2016 | 146.63 Billion INR | 7.43% |
| 2015 | 136.49 Billion INR | 13.34% |
| 2014 | 120.42 Billion INR | 49.81% |
| 2013 | 80.38 Billion INR | 39.01% |
| 2012 | 57.82 Billion INR | 26.99% |
| 2011 | 45.53 Billion INR | 3.93% |
| 2010 | 43.81 Billion INR | 22.54% |
| 2009 | 35.75 Billion INR | 16.19% |
| 2008 | 30.77 Billion INR | 26.33% |
| 2007 | 24.35 Billion INR | 14.74% |
| 2006 | 21.22 Billion INR | 33.21% |
| 2005 | 15.93 Billion INR | 20.58% |
| 2004 | 13.21 Billion INR | -12.16% |
| 2003 | 15.04 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 75.67 Billion INR | -0.17% |
| 2023 Q2 | 71.5 Billion INR | 5.3% |
| 2023 Q3 | 72.71 Billion INR | 1.69% |
| 2023 Q4 | 75.8 Billion INR | 4.25% |
| 2023 FY | 290.01 Billion INR | 17.81% |
| 2023 Q1 | 67.9 Billion INR | 6.46% |
| 2022 FY | 246.17 Billion INR | 5.35% |
| 2022 Q2 | 56.73 Billion INR | -8.15% |
| 2022 Q1 | 61.76 Billion INR | 6.58% |
| 2022 Q3 | 63.87 Billion INR | 12.59% |
| 2022 Q4 | 63.78 Billion INR | -0.15% |
| 2021 Q2 | 58.89 Billion INR | 3.48% |
| 2021 Q3 | 59.89 Billion INR | 1.69% |
| 2021 Q4 | 57.95 Billion INR | -3.24% |
| 2021 Q1 | 56.91 Billion INR | -5.0% |
| 2021 FY | 233.66 Billion INR | -4.85% |
| 2020 Q2 | 63.77 Billion INR | 9.3% |
| 2020 Q3 | 63.53 Billion INR | -0.39% |
| 2020 FY | 245.57 Billion INR | 8.0% |
| 2020 Q4 | 59.91 Billion INR | -5.69% |
| 2020 Q1 | 58.35 Billion INR | -3.76% |
| 2019 Q1 | 54.44 Billion INR | 9.89% |
| 2019 FY | 227.37 Billion INR | 18.27% |
| 2019 Q4 | 60.63 Billion INR | 4.55% |
| 2019 Q3 | 57.99 Billion INR | 3.55% |
| 2019 Q2 | 56 Billion INR | 2.86% |
| 2018 Q1 | 42.5 Billion INR | 4.97% |
| 2018 FY | 192.25 Billion INR | 18.68% |
| 2018 Q4 | 49.54 Billion INR | -5.98% |
| 2018 Q3 | 52.69 Billion INR | 10.91% |
| 2018 Q2 | 47.51 Billion INR | 11.79% |
| 2017 Q1 | 36.78 Billion INR | 1.02% |
| 2017 FY | 161.99 Billion INR | 10.47% |
| 2017 Q4 | 40.49 Billion INR | -6.62% |
| 2017 Q3 | 43.36 Billion INR | -2.25% |
| 2017 Q2 | 44.35 Billion INR | 20.58% |
| 2016 Q3 | 39.06 Billion INR | 3.46% |
| 2016 FY | 146.63 Billion INR | 7.43% |
| 2016 Q2 | 37.75 Billion INR | 1.33% |
| 2016 Q1 | 37.25 Billion INR | -0.53% |
| 2016 Q4 | 36.41 Billion INR | -6.77% |
| 2015 Q2 | 33.33 Billion INR | 0.39% |
| 2015 Q4 | 37.45 Billion INR | 7.16% |
| 2015 Q3 | 34.95 Billion INR | 4.86% |
| 2015 Q1 | 33.2 Billion INR | 7.65% |
| 2015 FY | 136.49 Billion INR | 13.34% |
| 2014 Q1 | 29.11 Billion INR | 28.32% |
| 2014 FY | 120.42 Billion INR | 49.81% |
| 2014 Q4 | 30.84 Billion INR | -2.58% |
| 2014 Q3 | 31.66 Billion INR | 9.89% |
| 2014 Q2 | 28.81 Billion INR | -1.03% |
| 2013 FY | 80.38 Billion INR | 39.01% |
| 2013 Q4 | 22.68 Billion INR | 5.98% |
| 2013 Q1 | 17.15 Billion INR | 14.54% |
| 2013 Q2 | 19.13 Billion INR | 11.56% |
| 2013 Q3 | 21.4 Billion INR | 11.85% |
| 2012 FY | 57.82 Billion INR | 26.99% |
| 2012 Q4 | 14.97 Billion INR | -4.61% |
| 2012 Q3 | 15.7 Billion INR | 4.64% |
| 2012 Q1 | 12.14 Billion INR | 8.72% |
| 2012 Q2 | 15 Billion INR | 23.55% |
| 2011 Q3 | 12.84 Billion INR | 0.0% |
| 2011 Q4 | 11.17 Billion INR | -13.04% |
| 2011 FY | 45.53 Billion INR | 3.93% |
| 2010 FY | 43.81 Billion INR | 22.54% |
| 2009 FY | 35.75 Billion INR | 16.19% |
| 2008 FY | 30.77 Billion INR | 26.33% |
| 2007 FY | 24.35 Billion INR | 14.74% |
| 2006 FY | 21.22 Billion INR | 33.21% |
| 2005 FY | 15.93 Billion INR | 20.58% |
| 2004 FY | 13.21 Billion INR | -12.16% |
| 2003 FY | 15.04 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Hikal Limited | 17.84 Billion INR | -1525.119% |
| Morepen Laboratories Limited | 17.01 Billion INR | -1604.089% |
| Innova Captab Limited | 10.81 Billion INR | -2582.117% |
| Albert David Limited | 3.62 Billion INR | -7901.361% |
| Alembic Limited | 1.57 Billion INR | -18315.605% |
| Alkem Laboratories Limited | 126.67 Billion INR | -128.946% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | -374.498% |
| Bafna Pharmaceuticals Limited | 1.52 Billion INR | -18921.898% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -6026.061% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -72340.746% |
| Brooks Laboratories Limited | 794.86 Million INR | -36386.719% |
| Eris Lifesciences Limited | 20.09 Billion INR | -1343.495% |
| FDC Limited | 19.42 Billion INR | -1392.677% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | -1170.221% |
| Gufic Biosciences Limited | 8.06 Billion INR | -3495.277% |
| Hester Biosciences Limited | 3.04 Billion INR | -9422.985% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -2164.179% |
| Ind-Swift Limited | 5.02 Billion INR | -5671.883% |
| IOL Chemicals and Pharmaceuticals Limited | 21.32 Billion INR | -1259.809% |
| Ipca Laboratories Limited | 77.05 Billion INR | -276.36% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -13796.307% |
| Jubilant Pharmova Limited | 67.02 Billion INR | -332.676% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -18686.941% |
| Laurus Labs Limited | 50.01 Billion INR | -479.829% |
| Lincoln Pharmaceuticals Limited | 5.8 Billion INR | -4895.589% |
| Mangalam Drugs & Organics Limited | 3.67 Billion INR | -7794.81% |
| Medico Remedies Limited | 1.44 Billion INR | -19912.234% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -1621.618% |
| RPG Life Sciences Limited | 5.82 Billion INR | -4882.711% |
| Sigachi Industries Limited | 3.98 Billion INR | -7169.439% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -2241.901% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 40.198% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -2658.526% |
| Themis Medicare Limited | 3.81 Billion INR | -7496.87% |
| Unichem Laboratories Limited | 16.57 Billion INR | -1649.824% |
| Vaishali Pharma Limited | 862.79 Million INR | -33513.782% |
| Venus Remedies Limited | 5.91 Billion INR | -4803.523% |
| Windlas Biotech Limited | 6.3 Billion INR | -4496.496% |
| ZIM Laboratories Limited | 3.67 Billion INR | -7791.3% |
| Orchid Pharma Limited | 8.19 Billion INR | -3439.541% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -2419.142% |
| Wanbury Limited | 5.75 Billion INR | -4938.11% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -1497.455% |
| Aarti Drugs Limited | 25.28 Billion INR | -1046.964% |
| Lupin Limited | 196.56 Billion INR | -47.545% |
| Sakar Healthcare Limited | 1.54 Billion INR | -18711.947% |
| Divi's Laboratories Limited | 78.45 Billion INR | -269.686% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -2138.61% |
| Mankind Pharma Limited | 103.34 Billion INR | -180.624% |
| Sequent Scientific Limited | 13.69 Billion INR | -2017.341% |
| Neuland Laboratories Limited | 15.58 Billion INR | -1760.787% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.47 Billion INR | -741.202% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | -145.506% |
| Zydus Lifesciences Limited | 190.21 Billion INR | -52.469% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -6785.036% |
| Wockhardt Limited | 27.89 Billion INR | -939.866% |
| Bal Pharma Limited | 3.39 Billion INR | -8449.586% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | -3.888% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -3665.279% |
| Par Drugs and Chemicals Limited | 956.4 Million INR | -30223.869% |
| Caplin Point Laboratories Limited | 16.76 Billion INR | -1629.617% |
| Shilpa Medicare Limited | 11.53 Billion INR | -2415.107% |
| Valiant Laboratories Limited | 1.82 Billion INR | -15830.087% |
| Ajanta Pharma Limited | 42.08 Billion INR | -589.092% |
| Aarey Drugs & Pharmaceuticals Limited | 3.95 Billion INR | -7230.778% |
| Granules India Limited | 45.06 Billion INR | -543.575% |
| Medicamen Biotech Limited | 1.79 Billion INR | -16074.494% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -11087.094% |
| Piramal Enterprises Limited | 60.33 Billion INR | -380.662% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | -173.462% |
| NATCO Pharma Limited | 40.02 Billion INR | -624.684% |
| Suven Life Sciences Limited | 116.92 Million INR | -247929.745% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -57418.856% |
| Strides Pharma Science Limited | 40.51 Billion INR | -615.897% |
| Indoco Remedies Limited | 18.17 Billion INR | -1495.886% |
| Alpa Laboratories Limited | 1.08 Billion INR | -26571.084% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -27696.875% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -38290.039% |